Abstract:Objective To determine whether HBV DNA polymerase is associated with T-cell failure and thus mediates the immune escape of HBV-related hepatocellular carcinoma(HCC)tumor cells,and to investigate the specific molecular mechanisms.Methods Liver cancer cell lines Huh7 and HepG2 stably transfected with HBV DNA polymerase expression plasmid with Flag(Flag-HBV-P)and intercellular adhesion molecule-1(ICAM1)were co-cultured with Jurkat cells,and MTT assay,qRT-PCR,and ELISA were used to measure Jurkat cell proliferation,activation(CD69 expression),and secretion of the cytokine IFN-γ.RNA-seq was used to screen for differentially expressed immune-associated molecules between stably transfected cell lines and control cells,and mRNA half-life and protein half-life assays were used to determine the specific levels of the immune-associated molecules that were affected by HBV DNA polymerase.Related websites were used to predict the transcription factors that may bind to the promoter region of this immune-associated molecule,Western blot was used to verify the effect of transcription factors on the immune-associated molecule,and rescue experiment was used to determine whether HBV DNA polymerase affects the expression level of the immune-associated molecule through this transcription factor.The independent-samples t test was used for comparison between two groups.Results The experimental group had significant reductions in Jurkat cell proliferation,activation,and cytokine secretion compared with the control group(all P＜0.01).Compared with the control group,the experimental group(Huh7 and HepG2 cell lines)had significant reductions in the mRNA and protein expression levels of ICAM1(all P＜0.01).Website prediction identified the ICAM1 promoter and preliminarily highlighted NFKB1,RELA,and STAT3.Compared with the control group,the experimental group(Huh7 and HepG2 cell lines)had a significant reduction in the protein expression level of p65(all P＜0.01).After p65 overexpression,there was a significant increase in the protein expression level of ICAM1,and after the expression of p65 was reduced,there was a significant reduction in the protein expression level of ICAM1(all P＜0.01).In the rescue experiment,there was no significant difference in the protein expression level of ICAM1 between the control group and the experimental group after p65 overexpression(all P＞0.05).After the overexpression of ICAM1,there were no significant differences in the proliferation,activation,and cytokine secretion of Jurkat cells between the control group and the experimental group(Huh7 and HepG2 cell lines)(all P＞0.05).Conclusion HBV DNA polymerase downregulates the level of ICAM1 to mediate HCC immune escape by inhibiting the expression of p65 in NF-κB.

HBV DNA polymerase regulates tumor cell glycogen to enhance the malignancy of HCC cells

HBV Rewires Liver Cancer Signaling by Altering PP2A Complexes

Hepatitis B Virus X Protein Promotes Tumor Glycolysis by Downregulating Lncrna OIP5-AS1/HKDC1 in HCC

Abstract 4891: Hepatitis B Virus Remodels Host Protein Interaction Networks to Generate Distinct Cellular Dependencies

A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma.

HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Hepatitis B Virus P Protein Initiates Glycolytic Bypass in HBV-related Hepatocellular Carcinoma Via a FOXO3/miRNA-30b-5p/MINPP1 Axis

Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein

Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Tissue Transglutaminase 2 Exerts a Tumor-Promoting Role in Hepatitis B Virus-Related Hepatocellular Carcinoma.

BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming

Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis

Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis

Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression

Aerobic glycolysis supports hepatitis B virus protein synthesis through interaction between viral surface antigen and pyruvate kinase isoform M2

HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma

HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein

Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan

HBx promotes tumorigenicity through RRM2-mediated autophagy in hepatocellular carcinoma

Changes in Glucose-6-phosphate Dehydrogenase Expression Results in Altered Behavior of HBV-associated Liver Cancer Cells.

Role of HBV DNA polymerase in mediating the immune escape of tumor cells in HBV-related hepatocellular carcinoma